News

Filter

Daiichi Sankyo to support Phase I clinical study of anticoagulant activity reverser for edoxaban

25-04-2013

USA-based Perosphere and Japanese drug major Daiichi Sankyo(TYO: 4568) have entered into a clinical trial…

Cardio-vascularDaiichi SankyoedoxabanPER977PharmaceuticalResearch

COMPANY SPOTLIGHT

Menarini

Back to top